Tocilizumab reduces the unmanageable inflammatory reaction of a patient with Aicardi-Goutières syndrome type 7 during treatment with ruxolitinib

Abstract Background Aicardi-Goutières syndrome (AGS) is a rare hereditary early-onset encephalopathy characterized by upregulation of the type I interferon pathway, poorly responsive to conventional immunosuppression. Case presentation We describe a 7-year-old Chinese boy who developed symptoms at t...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Wei Wang, Siming Peng, Sihao Gao, Meiying Quan, Lijuan Gou, Changyan Wang, Zhixing Sun, Zhuo Li, Dongmei Lian, Hongmei Song
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2023-10-01
Serie:	Pediatric Rheumatology Online Journal
Soggetti:	Aicardi-Goutières syndrome Treatment
Accesso online:	https://doi.org/10.1186/s12969-023-00899-4
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!